UBS analyst Brian Meredith downgraded Allstate (NYSE: ALL) from Buy to Neutral with a price target of $261.00 (from $255.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE